AI assistant
Sending…
Athira Pharma, Inc. — Director's Dealing 2022
Nov 18, 2022
35038_dirs_2022-11-17_f7feb8b9-56fe-4e5c-ba20-f9c146b03ce1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2022-11-15
Reporting Person: MOEBIUS HANS (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-15 | Common Stock | P | 5000 | $3.2884 | Acquired | 65836 | Direct |
More from Athira Pharma, Inc.
Annual Report
2026
May 11
Registration Form
2026
Apr 1
Registration Form
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Feb 23
Major Shareholding Notification
2026
Feb 6
Registration Form
2026
Jan 20
Registration Form
2026
Jan 20